ReviewClinical rheumatology2020
Giant cell arteritis with normal inflammatory markers: case report and review of the literature.
Review in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Diagnostic Challenges and Modern Therapeutic Strategies in Giant Cell Arteritis.Diagnostics (Basel, Switzerland) · 2026Review
- Recurrent vertebrobasilar stroke in giant cell arteritis associated with progressive prostate carcinoma: a case report and literature review.Clinical rheumatology · 2026Review
- Article
- Prevalence, characteristics, and outcomes of patients with low baseline C-reactive protein in giant cell arteritis.Arthritis research & therapy · 2025Observational
- Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot.Rheumatology international · 2025Article
- Population-Based Performance of Inflammatory Markers in Giant Cell Arteritis.American journal of ophthalmology · 2025Article
- [Unclear cause of unilateral blindness with normal inflammation parameters].Zeitschrift fur Rheumatologie · 2024Article
- Silent Inflammation: A Case of Blurry Vision Raising Diagnostic Challenges in an Elderly Patient.Cureus · 2024Article
- New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study.Rheumatology international · 2023Article
- Utility of biomarkers and temporal artery biopsy length for investigating giant cell arteritis in Western Australia.International journal of rheumatic diseases · 2023Article
- Pembrolizumab-Induced Giant Cell Arteritis in the Setting of Urothelial Carcinoma.Neuro-ophthalmology (Aeolus Press) · 2023Article
- Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases.Current rheumatology reports · 2022Review
- Choroidal ischemia as one cardinal sign in giant cell arteritis.International journal of retina and vitreous · 2022Article
- Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries.Life (Basel, Switzerland) · 2022Article
- Normal inflammatory markers in giant cell arteritis with long-standing cranial and symptomatic large-vessel involvement.BMJ case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant cell arteritis (GCA) is a granulomatous vasculitis involving large- and middle-sized arteries, with a predilection for cranial arteries. In this paper, we aim to describe a case of a biopsy- and ultrasound-proven GCA, presenting with anterior ischemic optic neuropathy (AION) and normal CRP and ESR at diagnosis and during follow-up, and to review the literature on GCA cases with low inflammatory markers, with a particular focus on the presence of eye involvement. Both CRP and ESR are important in the diagnosis of GCA; occurrence of this disease with normal acute phase reactants is unusual but does not rule out the diagnosis. Headache and visual manifestations were the most common symptoms reported in these cases; therefore, patients with the clinical suspicion of GCA require immediate ultrasound and/or temporal artery biopsy for correct diagnosis and treatment initiation in order to avoid permanent visual loss.
Indexed as
Identifiers
32472460What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.